| Literature DB >> 28722441 |
Tim Kaminski1, Anders Gunnarsson1, Stefan Geschwindner1.
Abstract
Optical biosensors entered target-based small-molecule drug discovery more than two decades ago and have since transformed into a value-adding component in the decision-making process. Here, we briefly highlight the major application areas of optical biosensors and focus on desirable profiles of such platforms in order to ensure their effective use in small molecule drug discovery. Furthermore, we will emphasize current technology-based constraints and discuss experimental strategies to address these limitations as well as provide a view of necessary technology improvements for next generation platforms.Keywords: biolayer interferometry; drug discovery; kinetics; single molecule; small molecule; surface-plasmon resonance; waveguide-grating
Year: 2016 PMID: 28722441 DOI: 10.1021/acssensors.6b00735
Source DB: PubMed Journal: ACS Sens ISSN: 2379-3694 Impact factor: 7.711